Vaxil Short Term Coverage Ratios from 2010 to 2024

VXL Stock  CAD 0.01  0.00  0.00%   
Vaxil Bio Short Term Coverage Ratios yearly trend continues to be fairly stable with very little volatility. Short Term Coverage Ratios is likely to outpace its year average in 2024. During the period from 2010 to 2024, Vaxil Bio Short Term Coverage Ratios regression line of quarterly data had mean square error of  135,478 and geometric mean of  26.23. View All Fundamentals
 
Short Term Coverage Ratios  
First Reported
2010-12-31
Previous Quarter
5.96
Current Value
6.26
Quarterly Volatility
553.30969905
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vaxil Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxil Bio's main balance sheet or income statement drivers, such as Selling General Administrative of 114, Selling And Marketing Expenses of 17.1 or Other Operating Expenses of 241, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.9. Vaxil financial statements analysis is a perfect complement when working with Vaxil Bio Valuation or Volatility modules.
  
This module can also supplement various Vaxil Bio Technical models . Check out the analysis of Vaxil Bio Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vaxil Stock Analysis

When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.